Image of a father holding his son on his back, both are smiling on a navy blue background.

Home Phototherapy: Clinical Insights, Coverage, and Technology for Safer Prescribing

Broad insurance access + Phothera Cares = easier access with as little as $0* out-of-pocket costs!

See how the groundbreaking landmark LITE Study trial is shaping the future of patient care.

Discover how Phothera’s touchscreen controller with Guided Mode ensures safety, adherence, and peace of mind.

Board Certified Dermatologist at Pacific Skin Institute

Member of the American Academy of Dermatology, California Medical Association, & American Medical Associate

With nearly 100 peer-reviewed publications, Dr. Sivamani is dedicated to advancing integrative research that connects clinical and medical dermatology. His work boldly explores the intersections between Western dermatology and alternative medicine, offering fresh insights and innovative approaches. Join us as he shares his expertise and empowers healthcare providers to expand their understanding and elevate patient care.

Join Dr. Raja Sivamani as he shares evidence-based phototherapy best practices and the latest advancements in home phototherapy—including modern patient interfaces, expanded insurance access, and innovative prescribing technologies.

Guided Mode FAQ’s

What is Guided Mode?

Guided Mode is Phothera’s new built-in treatment protocol system that standardizes narrowband UVB dosing according to AAD clinical guidelines. It ensures the same precision and safety patients receive in-office — now at home.

Why is Phothera switching to Guided Mode in Q1 2026?

Beginning Q1, all new Phothera home phototherapy devices will include Guided Mode by default.
The transition is driven by improvements in patient safety, adherence, and efficacy — ensuring every patient receives a medically appropriate, evidence-based regimen automatically.

How does Guided Mode improve safety?

Automatically sets and limits dose escalation per protocol

Built-in lockout prevents overexposure

Monitors total cumulative dose for safety thresholds

Is this FDA-cleared?

Yes. Phothera’s Guided Mode technology is FDA-cleared.
No hardware change — the update is software-driven to ensure dosing precision.

Will patients notice a difference?

Patients will see a new “Guided Mode” treatment screen that automatically sets exposure times and treatment frequency.
They’ll also receive simplified instructions emphasizing adherence and built-in safety checks. No manual calibration is needed.

What about coverage — will insurance still pay?

Yes — coverage is unchanged and stronger than ever:

98% of Kaiser Permanente patients are fully covered

Phothera handles all claims, prior authorizations, and appeals

No upfront payment — devices ship once Rx is received

Phothera Cares offers $0 copay eligibility and payment plans for others

How fast can patients receive their device?

Most prescriptions are processed and shipped within 3 business days of Rx receipt.

What conditions are supported?

Guided Mode covers all existing clinical indications:
Psoriasis, Vitiligo, Atopic Dermatitis, CTCL/Mycosis Fungoides, and Chronic Pruritus.

Does Guided Mode change how I prescribe?

No — prescribing workflow remains identical. Skin type is required on the prescription.
Providers continue using the same Rx form. Guided Mode simply ensures each patient’s treatment plan follows evidence-based dosing automatically.

Who do I contact for questions or patient setup?

Mike Franks

Email: [email protected]

*Valid for only those who qualify